In addition, induction of the nucleoprotein YBX1 was shown to be involved in TKI-resistant JAK2-mediated MPN, as well as TKI-resistant CML highlighting deubiquitinating enzymes as potential biomarkers of TKI resistance. The gene discussed is YBX1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.